Abstract
Activation of the ras gene family by point mutation at codons 12, 13 and 61 has been demonstrated in up to 20% of unselected series of human tumours. The present study was carried out to assess the incidence of ras activation in 37 squamous cell carcinomas of the head and neck, seven squamous cell carcinomas of the skin and eight squamous carcinoma cell lines. Oligonucleotide probes and the polymerase chain reaction were used on DNA extracted from achival paraffin embedded material. Mutations in codon 12 of the Harvey ras gene was found in a carcinoma of the larynx and a carcinoma of the lip, both of which had received prior irradiation. A cell line (LICR-LON-HN8) established from the same laryngeal cancer showed the same mutation. This study indicates that there is a low incidence of ras mutation in human squamous cell carcinomas and that activation of this family of genes is probably not a common factor in the development of this group of tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rumsby, G., Carter, R. & Gusterson, B. Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer 61, 365–368 (1990). https://doi.org/10.1038/bjc.1990.80
Issue Date:
DOI: https://doi.org/10.1038/bjc.1990.80
This article is cited by
-
Behavioral Genetics of the Depression/Cancer Correlation: A Look at the Ras Oncogene Family and the ‘Cerebral Diabetes Paradigm’
Journal of Molecular Neuroscience (2008)
-
Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis
Journal of Cancer Research and Clinical Oncology (2007)
-
Binding of TGF-β1 latency-associated peptide (LAP) to αvβ6 integrin modulates behaviour of squamous carcinoma cells
British Journal of Cancer (2002)
-
Inhibition of Rel/Nuclear Factor-κB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development
Oncogene (2002)
-
Immunohistochemical expression of N-ras oncogene is a late event in head and neck carcinomas
Pathology & Oncology Research (1996)